An international research collaborative has determined that a promising anti-malarial compound tricks the immune system to rapidly destroy red blood cells infected with the malaria parasite but leave healthy cells unharmed.
St. Jude Children’s Research Hospital scientists led the study, which appears in the current online early edition of the Proceedings of the National Academy of Sciences (PNAS).
The compound, (+)-SJ733, was developed from a molecule identified in a previous St. Jude-led study that helped to jumpstart worldwide anti-malarial drug development efforts. Malaria is caused by a parasite spread through the bite of an infected mosquito. The disease remains a major health threat to more than half the world’s population, particularly children. The World Health Organization estimates that in Africa a child dies of malaria every minute.
In this study, researchers determined that (+)-SJ733 uses a novel mechanism to kill the parasite by recruiting the immune system to eliminate malaria-infected red blood cells. In a mouse model of malaria, a single dose of (+)-SJ733 killed 80 percent of malaria parasites within 24 hours. After 48 hours the parasite was undetectable.
Planning has begun for safety trials of the compound in healthy adults.
Laboratory evidence suggests that the compound’s speed and mode of action work together to slow and suppress development of drug-resistant parasites. Drug resistance has long undermined efforts to treat and block malaria transmission.
“Our goal is to develop an affordable, fast-acting combination therapy that cures malaria with a single dose,” said corresponding author R. Kiplin Guy, Ph.D., chair of the St. Jude Department of Chemical Biology and Therapeutics. “These results indicate that SJ733 and other compounds that act in a similar fashion are highly attractive additions to the global malaria eradication campaign, which would mean so much for the world’s children, who are central to the mission of St. Jude.”
Whole genome sequencing of the Plasmodium falciparum, the deadliest of the malaria parasites, revealed that (+)-SJ733 disrupted activity of the ATP4 protein in the parasites. The protein functions as a pump that the parasites depend on to maintain the proper sodium balance by removing excess sodium.
The sequencing effort was led by co-author Joseph DeRisi, Ph.D., a Howard Hughes Medical Institute investigator and chair of the University of California, San Francisco Department of Biochemistry and Biophysics. Investigators used the laboratory technique to determine the makeup of the DNA molecule in different strains of the malaria parasite.
Researchers showed that inhibiting ATP4 triggered a series of changes in malaria-infected red blood cells that marked them for destruction by the immune system. The infected cells changed shape and shrank in size. They also became more rigid and exhibited other alterations typical of aging red blood cells. The immune system responded using the same mechanism the body relies on to rid itself of aging red blood cells.
Another promising class of antimalarial compounds triggered the same changes in red blood cells infected with the malaria parasite, researchers reported. The drugs, called spiroindolones, also target the ATP4 protein. The drugs include NITD246, which is already in clinical trials for treatment of malaria. Those trials involve investigators at other institutions.
“The data suggest that compounds targeting ATP4 induce physical changes in the infected red blood cells that allow the immune system or erythrocyte quality control mechanisms to recognize and rapidly eliminate infected cells,” DeRisi said. “This rapid clearance response depends on the presence of both the parasite and the investigational drug. That is important because it leaves uninfected red blood cells, also known as erythrocytes, unharmed.”
Laboratory evidence also suggests that the mechanism will slow and suppress development of drug-resistant strains of the parasite, researchers said.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- Professor says possibility malaria could become endemic in Australiaon December 1, 2019 at 6:53 pm
An award-winning scientist has claimed malaria could re-emerge as a serious health problem in northern Australia. Professor Brendan Crabb, director and chief executive of the Burnet Institute, on ...
- Moonchild Sanelly is recovering after a serious encounter with malariaon November 30, 2019 at 3:00 pm
Local musician and dancer Moonchild Sanelly is on her way to being better after contracting malaria - She was taken to hospital in an ambulance and doctors said she was admitted just in time - The ...
- Malaria predictions based on seasonal climate forecasts in South Africa: A time series distributed lag nonlinear modelon November 29, 2019 at 2:05 am
Although there have been enormous demands and efforts to develop an early warning system for malaria, no sustainable system has remained. Well-organized malaria surveillance and high-quality climate ...
- Gene editing kills malaria carrying mosquitoeson November 28, 2019 at 2:45 am
Researchers in England wipe out a population of malaria carrying mosquitoes in a laboratory using gene editing, raising renewed hopes of eradicating the disease in the wild. Stuart McDill reports.
- New high-resolution images show how malaria parasites evade frontline drugson November 27, 2019 at 10:05 am
Images show how changes in a specific protein of the malaria parasite are causing a frontline treatment to lose effectiveness Results show how antimalarial resistance could spread out of Southeast ...
- Building a better malaria vaccineon November 27, 2019 at 6:11 am
As the first vaccine against the malaria parasite begins to roll out, scientists are working on a wide variety of alternatives that they hope will provide more protection. In 1991, when immunologist ...
- First malaria vaccine rolled out in Africa—despite limited efficacy and nagging safety concernson November 26, 2019 at 12:27 pm
The procedure is repeated for the other baby, a girl. It may sound routine, but it's not. These two children have just received the first malaria vaccine to move beyond the stage of clinical testing—a ...
- Malaria-fighting soup? On a lark, a school experiment leads to findings about homemade cureson November 26, 2019 at 8:51 am
(CNN) -- It started out as a project for National Science Week at his children's British primary school -- a way malaria researcher Jake Baum could teach the kids the difference between a herbal ...
- Global Drugs for Malaria Market 2019 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast to 2028on November 25, 2019 at 7:49 am
Nov 25, 2019 (AB Digital via COMTEX) -- New Market Study, Report "Drugs for Malaria Market 2019 Global Industry Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts ...
- Malaria: New chemical formulation for bed nets shows promising resultson November 22, 2019 at 5:18 am
An insecticide-treated bed net with piperonyl butoxide being assessed in Uganda in 2018. Photo by: LSTM MANILA — Long-lasting insecticide-treated bed nets have been a lifesaving tool against malaria, ...
via Bing News